IGC PHARMA, INC. Debt Instrument, Face Amount
IGC PHARMA, INC. (IGC) had Debt Instrument, Face Amount of $150.00 thousand as of 2020-06-11, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2026-08-14
- 2020-06-11: Debt Instrument, Face Amount $150.00K.
- 2020-05-03: Debt Instrument, Face Amount $430.00K.
- 2014-12-31: Debt Instrument, Face Amount $40.00K.
- 2014-09-30: Debt Instrument, Face Amount $40.00K.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2020-06-11 | $150.00K 10-Q · filed 2026-08-14 |
| 2020-05-03 | $430.00K 10-K · filed 2022-06-23 |
| 2014-12-31 | $40.00K 10-Q · filed 2015-02-12 |
| 2014-09-30 | $40.00K 10-Q · filed 2014-11-13 |
| 2014-03-31 | $40.00K 10-Q · filed 2014-08-14 |
| 2012-06-30 | $2.23M 10-Q/A · filed 2012-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |